ATOSSA THERAPEUTICS, INC. Prepaid Insurance
ATOSSA THERAPEUTICS, INC. (ATOS) had Prepaid Insurance of $227.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidInsurance · last filed 2026-08-07
- 2026-06-30: Prepaid Insurance $227.00K.
- 2026-03-31: Prepaid Insurance $370.00K.
- 2025-12-31: Prepaid Insurance $517.00K.
- 2025-09-30: Prepaid Insurance $103.00K.
| Period end | Prepaid Insurance | Prepaid Insurance as first filed |
|---|---|---|
| 2026-06-30 | $227.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $370.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $517.00K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $103.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $278.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $461.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $628.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $119.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $353.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $582.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $794.00K 10-K · filed 2025-03-25 | |
| 2023-09-30 | $158.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $509.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $520.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $387.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $155.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $579.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $613.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $461.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $136.88K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $522.18K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $554.40K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $418.00K 10-K · filed 2022-02-28 | $417.85K 10-K · filed 2021-03-31 |
| 2020-09-30 | $63.70K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $251.46K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $280.10K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $222.48K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $49.98K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $201.23K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $234.88K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $160.58K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $46.62K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $148.28K 10-Q/A · filed 2018-11-13 | |
| 2018-03-31 | $136.67K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $125.06K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $39.13K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $156.53K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $140.22K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $121.33K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $38.54K 10-Q/A · filed 2017-03-21 | |
| 2016-06-30 | $169.91K 10-Q/A · filed 2017-03-21 | |
| 2016-03-31 | $112.74K 10-Q/A · filed 2017-03-21 | |
| 2015-12-31 | $104.95K 10-K/A · filed 2017-03-21 | |
| 2015-09-30 | $41.67K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $119.89K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $103.65K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $87.63K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $36.80K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $89.97K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $125.71K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $112.52K 10-K · filed 2015-03-30 | |
| 2013-09-30 | $27.45K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $52.86K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $98.71K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $62.55K 10-K · filed 2014-03-27 | |
| 2012-09-30 | $2.47K 10-Q/A · filed 2013-01-22 | |
| 2011-12-31 | $14.15K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |